Basic Information
LncRNA/CircRNA Name | lncRNA-LET |
Synonyms | NPTN-IT1, lncRNA-LET |
Region | GRCh38_15:73567012-73569294 |
Ensemble | ENSG00000281183 |
Refseq | NR_103844 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, Western blot, RIP, in vitro knockdown etc. |
Sample | CRC tissues, cell lines (QSG-7701, LO2, SMMC-7721 etc.) |
Expression Pattern | down-regulated |
Function Description | Aberrant Expression of lncRNA-LET in Tumor Tissue. We found that the lncRNA-LET was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas. hypoxia-induced histone deacetylase 3 repressed lncRNA-LET by reducing the histone acetylation-mediated modulation of the lncRNA-LET promoter region. The downregulation of lncRNA-LET was found to be a key step in the stabilization of nuclear factor 90 protein, which leads to hypoxia-induced cancer cell invasion. |
Pubmed ID | 23395002 |
Year | 2013 |
Title | Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. |
External Links
Links for lncRNA-LET | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |